In the Past 30 Days...
PER WEEK
PER POST
PER POST
In the last 30 days, the average company in this landscape has grown their audience by <0.1%. Biologics by McKesson grew faster than everyone else, with 0.7% growth! On average, each post in this landscape earns more than 120.0 engagements. Abbott is topping the charts with more than 568.5 engagements per post on their 24 posts in the last 30 days.
1.16k Likes • 12 Comments
Less of a race, more of a 26.2 mile block party celebrating what’s possible with good health — that’s the nycmarathon. Have a story of how health and running have transformed your life? Apply for a chance to run the 2026 New York City Marathon with Team Abbott at the link in our bio by Monday, …
203 Likes • 2 Comments
As soccer takes the global stage, we’re not only counting goals — we’re focused on what helps athletes perform at every level: proper hydration. 💧
151 Likes • 0 Comments
Can listening differently help us solve tomorrow's most complex challenges? This week, 37 exceptional students from 34 European universities will arrive in Arles, France, to find out. Hosted in partnership with LUMA_Arles and Tour_du_Valat, Roche Continents 2026 explores our new theme: "Shared Frequencies". It’s not about forcing consensus, but listening across disciplines to find moments of collective …
106 Likes • 0 Comments
Only 7% of clinical trials succeed. That statistic inspired Squibby the mascot to guard our 7% Goal at the #FIFA2026 Fan Hub, challenging fans to take their shot and see if they could score. ⚽ Relive some of our favorite moments from the partnership with the FIFA World Cup 2026™ New York New Jersey Host Committee …
105 Likes • 1 Comments
Haemophilia A care goes beyond bleed control. It must be shaped by patient needs at every age and stage of life. 🩸 We’re focused on advancing science to help reduce both the physical and emotional burden of the condition for people living with haemophilia A, including babies and their families. #Haemophilia #BleedingDisorders #PatientCare
18 Reactions • 14 Comments • 0 Shares
Your one spot for affordable GLP-1 pricing — with or without insurance.
20 Reactions • 0 Comments • 0 Shares
Only 7% of clinical trials succeed. That statistic inspired Squibby to step into the goal at our 7% Goal activation during the #FIFA2026 Fan Hub, where fans tested their skills in a penalty shootout — and learned about the challenges of advancing scientific innovation. Take a look at some of our favorite moments from the partnership …
18 Reactions • 0 Comments • 1 Shares
“️To me, #BMSWontLose means showing yourself grace during your hardest moments.” Meet our colleague Fanta, who generously volunteered to help #FIFA2026 World Cup visitors and reinforced the power of community and our commitment to patients during the world’s biggest sports event. Watch her video diary of the experience and learn about our mission to bring victory …
11 Reactions • 0 Comments • 0 Shares
⚽ Just as football unites the world, Roche is united by a single purpose: doing now what patients need next. We combine life-changing diagnostics and medicines to take on the toughest healthcare challenges, those that place the greatest strain on patients, families, communities and health systems. Guided by the experiences of patients, we are determined to prevent, …
4 Reactions • 0 Comments • 0 Shares
Non-squamous non-small cell lung cancer (NSCLC) is the most common type of lung cancer, but it can still be difficult to diagnose and treat. This is especially true when the disease involves specific genetic changes, which can make the cancer progress more quickly. Patients with NSCLC and HER2 mutations need targeted therapy—and that can be hard …
13 Likes • 3 Retweets
The first fully automated diagnostic solution to identify the most severe form of viral hepatitis is finally here, helping clinicians address the urgent need for a consistent, widely accessible solution. roche.com/media $RHHBY $ROG Available in countries accepting the pic.x.com/oSh1VSdKlL
8 Likes • 3 Retweets
#InTheNews: Following FDA approval of our treatment for first-line metastatic triple-negative breast cancer (mTNBC), watch coverage highlighting the impact for patients facing one of the most aggressive cancers: gilead.inc/4f5PGSN pic.x.com/nqF5PYc3Fh
7 Likes • 1 Retweets
We're at #AAIC26! Come by booth to speak to our team about the latest advancements in Alzheimer’s. We look forward to meeting you! 👋 pic.x.com/ilQHTf3Wpk
9 Likes • 2 Retweets
Just 19 minutes per patient to process. Under 24 hours to results. ⏱️ A new blood test for tuberculosis infection is giving labs the efficiency they need to handle growing global testing demands. Faster testing means we're one step closer to global TB elimination. 🌍 pic.x.com/73HYRcBIt2
5 Likes • 2 Retweets
Some things haven't changed during our 138-year history, including people's pursuit of good health. And no matter where you are in your journey today, we're here to help you live a healthier, fuller life. We're continuing to shape the future of healthcare as one of America's pic.x.com/avUwVWLNl4
The Social Media Benchmark Report
Ready to see how you stack up to your industry’s top social performers? Review the latest metrics on channels, engagement, post types, and more.